Polytetrafluoroethylene Grafts as the First-Choice Arterial Substitute in Femoropopliteal Revascularization

William J. Quinones Baldrich, Vicente Martin Paredero, J. Dennis Baker, Ronald W. Busuttil, Herbert I. Machleder, Wesley S. Moore

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


• We studied a series of femoropopliteal bypass operations in which polytetrafluoroethylene (PTFE) grafts were used as the first choice, regardless of the availability of saphenous vein. From Jan 1, 1979 to Dec 31,1982,63 PTFE femoropopliteal bypass grafts were placed in 55 patients without exploration of the saphenous vein. Forty-three grafts were placed for limb salvage, and 20 grafts were placed for disabling claudication. Patients were followed up for nine to 53 months (average, 23 months). The operative mortality was 1.8%. There were no infections. The overall patency at 30 months was 76.1%. The 30 months' cumulative patency rate for patients with claudication was 89.3%, and there were no amputations. The cumulative 30-month patency for limb salvage was 70.1%, and there was a limb salvage rate of 81.2%. Because the 30-month results were comparable with reported series using autogenous saphenous vein, we concluded that PTFE conduits may be considered the first-choice arterial substitute for femoropopliteal reconstruction. Until longer follow-ups are available, reversed autogenous saphenous vein should probably be the graft of first choice in younger patients (less than 60 years of age) without coronary artery disease who are undergoing femoropopliteal revascularizations.

Original languageEnglish (US)
Pages (from-to)1238-1243
Number of pages6
JournalArchives of Surgery
Issue number11
StatePublished - Nov 1984

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Polytetrafluoroethylene Grafts as the First-Choice Arterial Substitute in Femoropopliteal Revascularization'. Together they form a unique fingerprint.

Cite this